A novel approach to treating neurodegenerative disease
b'In this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, part of Clarivate, speaks with Dr. Leen Kawas, president and CEO of Athira Pharma. Dr. Kawas shares the company\\u2019s innovative approach to treating Alzheimer\\u2019s disease by developing small molecules to restore neuronal health and stop neurodegeneration. They also discuss Athira\\u2019s recent IPO following a successful series B funding round, all during the pandemic.\\xa0
Hosted on Acast. See acast.com/privacy for more information.
'